Newsletter Archive

  1. 08.07.26 -- New Podcast Episodes: BoB@BIO, In Vivo Gene Editing, Multispecific Manufacturability, and More 8/7/2026
    08/07/26 Bioprocess Online Newsletter
  2. 08.07.26 -- Digitalizing The Biopharma Ecosystem With Kat Kozyrytska 8/7/2026
    08/07/26 Bioprocess Online Newsletter
  3. 08.07.26 -- BIO 2026: Modernizing The FDA And Bolstering The Workforce 8/7/2026
    08/07/26 Bioprocess Online Newsletter
  4. 08.06.26 -- Fermentation Solutions For Scaling Upstream Bioprocessing With More Control 8/6/2026
    08/06/26 Bioprocess Online Newsletter
  5. 08.06.26 -- As In Vivo Therapies Scale, Vector Supply Becomes Critical 8/6/2026

    08/06/26 Bioprocess Online Newsletter

  6. 08.06.26 -- Avoiding Common Pitfalls In CDMO–Sponsor Relationships Through Integrated Execution Models 8/6/2026
    08/06/26 Bioprocess Online Newsletter
  7. 08.05.26 -- Preparing For What's Next In Regulated Manufacturing 8/5/2026

    08/05/26 Bioprocess Online Newsletter

  8. 08.05.26 -- Demonstrating Non-Inferiority Of BFPCs Vs. Traditional Air Monitoring 8/5/2026
    08/05/26 Bioprocess Online Newsletter
  9. 08.04.26 -- De-Risk MSC Development From Source To Scale 8/4/2026

    08/04/26 Bioprocess Online Newsletter

  10. 08.04.26 -- CDMO Capacity Remains Tight — How To Avoid A Costly Partner Mistake 8/4/2026
    08/04/26 Bioprocess Online Newsletter